Inventor · disambiguated record
Marcus Rudolf Götz
Also filed as: GOETZ MARCUS · GÖTZ MARCUS · GÖTZ MARCUS RUDOLF
12 granted patents·4 pending applications·29 citations·filing 2013–2021
86Inventor score
Top patents by PatentIndex Score
16 records- 0190US9670133B2Mixtures of cannabinoid compounds, and production and use thereofSYMRISE AG·Filed 2014·Granted Jun 6, 2017·16 cites·10 claims
- 0289US10647691B2Method for purifying cannabinoid compoundsSYMRISE AG·Filed 2016·Granted May 12, 2020·5 cites·20 claims
- 0386US10893695B2Probiotic bacterial strain of Lactobacillus plantarum and compositions and uses thereof in the treatment of inflammationPROBI AB·Filed 2018·Granted Jan 19, 2021·2 cites·13 claims
- 0483US10913729B2Mixtures of cannabinoid compounds, and production and use thereofSYMRISE AG·Filed 2018·Granted Feb 9, 2021·1 cites·15 claims
- 0578US8906958B2Compounds and mixtures for influencing inflammatory statesSYMRISE AG·Filed 2013·Granted Dec 9, 2014·4 cites·18 claims
- 0674US11020441B2Probiotics for use as anti-inflammatory agents in the oral cavitySYMRISE AG·Filed 2017·Granted Jun 1, 2021·1 cites·6 claims
- 0770US11964955B2Mixtures of cannabinoid compounds, and production and use thereofSYMRISE AG·Filed 2020·Granted Apr 23, 2024·0 cites·18 claims
- 0868US12491145B2Synthesis and purification of cannabigerol and its applicationSYMRISE AG·Filed 2019·Granted Dec 9, 2025·0 cites·8 claims
- 0963US11033589B2Oral dosage formSYMRISE AG·Filed 2019·Granted Jun 15, 2021·0 cites·5 claims
- 1054US11198848B2Probiotics for altering the composition of oral biofilmsSYMRISE AG·Filed 2017·Granted Dec 14, 2021·0 cites·17 claims
- 1149US11338001B2Probiotics for aggregation with disease-associated species in the oral cavitySYMRISE AG·Filed 2018·Granted May 24, 2022·0 cites·7 claims
- 1249US2018244642A1Mixtures of cannabinoid compounds, and production and use thereofSYMRISE AG·Filed 2016·Application pending·0 cites
- 1345US2017071988A1Oral dosage formSymriseAG·Filed 2016·Application pending·0 cites
- 1444US2013251730A1Compounds and Mixtures Influencing Inflammatory StatesSYMRISE AG·Filed 2013·Application pending·0 cites
- 1544US2024122834A1Medicament for prevention and treatment of hyperpigmentationSYMRISE AG·Filed 2021·Application pending·0 cites
- 1642US11485700B2Synthesis of (+)-cannabinoids and their therapeutic effectsSYMRISE AG·Filed 2018·Granted Nov 1, 2022·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Marcus Rudolf Götz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →